Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D. Wood, G. De Backer, O. Faergeman, I. Graham, G. Mancia, K. Pyorala, et al.
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
Atherosclerosis, 140 (1998), pp. 199-270
[2.]
Ministerio de Sanidad y Consumo, Sociedad Española de Cardiología y Sociedad Española de Arteriosclerosis. Control de la colesterolemia en España, 2000. Un instrumento para la prevención cardiovascular.
Clin Invest Arterioscler, 12 (2000), pp. 125-152
[3.]
International Lipid Information Bureau. The ILIB lipid handbook for clinical practice. Blood lipids and coronary heart disease, 2a,
[4.]
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
JAMA, 285 (2001), pp. 2486-2497
[5.]
P.W. Wilson, R.B. D’Agostino, D. Levy, A.M. Belanger, H. Silvershatz, W.B. Kannel.
Prediction of coronary heart disease using risk factor categories.
Circulation, 97 (1998), pp. 1837-1847
[6.]
K. Kuulasmaa, H. Tunstall-Pedoe, A. Dobson, S. Fotmann, S. Sans, H. Tolonen, et al.
for the WHO-MONICA Project. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.
Lancet, 355 (2000), pp. 675-687
[7.]
J. Stamler, R. Stamler, J.D. Neaton, D. Wentworth, M.L. Daviglus, D. Garside, et al.
Low-risk factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.
JAMA, 282 (1999), pp. 2012-2018
[8.]
T.A. Jacobson, G.G. Griffiths, C. Varas, D. Gause, J.C. Sung, C.M. Ballantyne.
Impact of evidence-based “clinical judgment” on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data: National Health and Nutrition Examination Survey.
Arch Intern Med, 160 (2000), pp. 1361-1369
[9.]
P. Greenland, J. Abrams, G.P. Aurigemma, M.G. Bond, L.T. Clark, M.H. Criqui, et al.
AHA Conference Proceedings. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden.
Circulation, 101 (2000), pp. 16-22
[10.]
P. Greenland, S.C. Smith, S.M. Grundy.
Current Perspective. Improving coronary risk assessment in asymptomatic people: role of traditional risk factors and non-invasive cardiovascular tests.
Circulation, 104 (2001), pp. 1863-1867
[11.]
L.W. Gibbons, T.L. Mitchell, M. Wei, S.N. Blair, K.H. Cooper.
Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men.
Am J Cardiol, 86 (2000), pp. 53-68
[12.]
M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, T.J. Mc-Cann, et al.
Mortality over a period of 10 years in patients with peripheral arterial disease.
N Engl J Med, 326 (1992), pp. 381-386
[13.]
M.H. Criqui, A. Fronek, E. Barrett-Connor, M.R. Klauber, S. Gabriel, D. Goodman.
The prevalence of peripheral arterial disease in a defined population.
Circulation, 71 (1985), pp. 510-515
[14.]
P. Pignoli, E. Tremoli, A. Poli, P. Oreste, R. Paoletti.
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Circulation, 74 (1986), pp. 1399-1406
[15.]
J. Persson, L. Stavenow, J. Wikstrand, B. Israelsson, J. Formgren, G. Berglund.
Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size.
Arterioscler Thromb, 12 (1992), pp. 261-266
[16.]
I. Wendelhag, T. Gustavsson, M. Suurküla, G. Berglund, J. Wikstrand.
Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized system.
Clin Physiol, 11 (1991), pp. 565-577
[17.]
M. Wong, J. Edelstein, M.G. Bond.
Ultrasonic-pathological comparison of the human arterial wall: verification of intima-media thickness.
Arterioscler Thromb, 13 (1993), pp. 482-486
[18.]
J. Persson, J. Formgren, B. Israelsson, G. Berglund.
Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation.
Arterioscler Thromb, 14 (1994), pp. 261-264
[19.]
M.L. Bots, A. Hofman, D.E. Grobee.
Commom carotid intima-media thickness and lower extremity arterial atherosclerosis: the Rotterdam Study.
Arterioscler Thromb, 14 (1994), pp. 1885-1891
[20.]
D.H. O’Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, S.K. Wolfson Jr..
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study.
N Engl J Med, 340 (1999), pp. 14-22
[21.]
J.D. Barth.
Which tools are in your cardiac workshop? Carotid ultrasound, endothelial function, and magnetic resonance imaging.
Am J Cardiol, 87 (2001), pp. 8-14
[22.]
D. Baldassarre, M. Amato, A. Bondioli, C.R. Sirtori, E. Tremoli.
Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors.
Circulation, 31 (2000), pp. 2426-2430
[23.]
G. Heiss, A.R. Sharrett, R. Barnes, L.E. Chambless, M. Szklo, C. Alazola.
for the ARIC Investigators. Carotid atherosclerosis measured with B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study.
Am J Epidemiol, 134 (1991), pp. 250-256
[24.]
D. Zambón, R. Gilabert, E. Ros, E. Casals, C. Sanllehy, C. Rodríguez, et al.
Aterosclerosis carotídea evaluada por ecografía bidimensional en pacientes con hipercolesterolemia primaria.
Med Clin (Barc), 105 (1995), pp. 761-767
[25.]
S. Ebrahim, O. Papacosta, P. Whincup, G. Wannamethee, M. Walker, A.N. Nicolaides, et al.
Carotid plaque, intima-media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.
Stroke, 30 (1999), pp. 841-850
[26.]
C. Fernández-Miranda, J.L. Aranda, M. Paz, V. Núñez, P. Gómez González, P. Díaz-Rubio, et al.
Aterosclerosis subclínica de la arteria carótida en pacientes con enfermedad coronaria.
Med Clin (Barc), 116 (2001), pp. 441-445
[27.]
L.E. Chambless, A.R. Folsom, V. Davis, R. Sharrett, G. Heiss, P. Sorlie, et al.
Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998.
Am J Epidemiol, 155 (2002), pp. 38-47
[28.]
D.H. Blankenhorn, R.H. Selzer, D.W. Crawford, J.D. Barth, C.R. Liu, C.H. Liu, et al.
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
Circulation, 88 (1993), pp. 20-28
[29.]
J.T. Salonen, R. Salonen.
Ultrasonographically assessed carotid morphology and the risk of coronary heart disease.
Arterioscler Thromb, 11 (1991), pp. 1245-1249
[30.]
M.L. Bots, A.W. Hoes, P.J. Koudstaal, A. Hofman, D.E. Grobbee.
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.
Circulation, 96 (1997), pp. 1432-1737
[31.]
L.E. Chambless, G. Heiss, A.R. Folsom, W. Rosamond, M. Szklo, A.R. Sharrett, et al.
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.
Am J Epidemiol, 146 (1997), pp. 483-494
[32.]
H.N. Hodis, W.J. Mack, L. LaBree, R.H. Selzer, C.R. Liu, C.H. Liu, et al.
The role of carotid arterial intima-media thickness in predicting clinical coronary events.
Ann Intern Med, 128 (1998), pp. 262-269
[33.]
L.E. Chambless, A.R. Folsom, L.X. Clegg, A.R. Sharrett, E. Shahar, F.J. Nieto, et al.
Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.
Am J Epidemiol, 151 (2000), pp. 478-487
[34.]
A. Aminbakhsh, G.B. Mancini.
Carotid intima-media thickness measurements: what defines an abnormality? A systematic review.
Clin Invest Med, 22 (1999), pp. 149-157
[35.]
G. Belcaro, A.N. Nicolaides, G. Laurora, M.R. Cesarone, M. De Sanctis, L. Incandela, et al.
Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study.
Arterioscler Thromb Vasc Biol, 16 (1996), pp. 851-856
[36.]
S. Ebrahim, O. Papacosta, P. Whincup, G. Wannamethee, M. Walker, A.N. Nicolaides, et al.
Carotid plaque, intima-media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. The British Regional Heart Study.
Stroke, 30 (1999), pp. 841-850
[37.]
E.B. Mathiesen, K.H. Boonaa, O. Joakimsen.
Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis. The Tromso Study.
Circulation, 103 (2001), pp. 2171-2175
[38.]
M.L. Gonholdt, B.G. Nordestgaard, T.V. Schroeder, S. Vorstrup, H. Sillesen.
Ultrasonic echolucent carotid plaques predict future strokes.
Circulation, 104 (2001), pp. 68-73
[39.]
H.S. Hecht.
New developments in atherosclerosis imaging: electron beam tomography.
Curr Atheroscler Rep, 3 (2001), pp. 417-424
[40.]
T.Q. Callister, P. Raggi, B. Cooil, N.J. Lippolis, D.J. Russo.
Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
N Engl J Med, 339 (1998), pp. 1972-1978
[41.]
R.A. O’Rourke, B.H. Brundage, V.G. Froelicher.
American College of Cardiology/ American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.
Circulation, 102 (2000), pp. 126-140
[42.]
Y. Arad, L.A. Spadaro, K. Goodman, D. Newstein, A.D. Guerci.
Prediction of coronary events with electron beam computed tomography.
J Am Coll Cardiol, 36 (2000), pp. 1253-1260
[43.]
R. Wayhs, A. Zelinger, P. Raggi.
High coronary artery calcium scores pose an extremely elevated risk for hard events.
J Am Coll Cardiol, 39 (2000), pp. 225-230
[44.]
R.C. Detrano, N.D. Wong, T.M. Doherty, R.M. Shavelle, W. Tang, L.E. Ginzton, et al.
Coronary calcium does not accurately predict nearterm future coronary events in high risk adults.
Circulation, 99 (1999), pp. 2633-2638
[45.]
W.J. Manning, W. Li, R.R. Edelman.
A preliminary report comparing magnetic resonance coronary angiography with conventional angiography.
N Engl J Med, 328 (1993), pp. 828-832
[46.]
Z.A. Fayad, V. Fuster, J.T. Fallon, T. Jayasundera, S.G. Worthley, G. Helft, et al.
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging.
Circulation, 102 (2000), pp. 506-510
[47.]
S. Moncada, A. Higgs.
The L-arginine-nitric oxide pathway.
N Engl J Med, 329 (1993), pp. 2002-2012
[48.]
D.S. Celermajer.
Endothelial dysfunction: does it matter? Is it reversible?.
J Am Coll Cardiol, 30 (1997), pp. 325-333
[49.]
H. Drexler.
Endothelial dysfunction: clinical implications.
Progr Cardiovasc Dis, 39 (1997), pp. 287-332
[50.]
T.J. Anderson.
Assessment and treatment of endothelial dysfunction in humans.
J Am Coll Cardiol, 34 (1999), pp. 631-638
[51.]
P.L. Ludmer, A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, R.W. Alexander, P. Gantz.
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.
N Engl J Med, 315 (1986), pp. 1046-1051
[52.]
D.A. Cox, J.A. Vita, C.B. Treasure, R.D. Fish, R.W. Alexander, P. Ganz, et al.
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans.
Circulation, 80 (1989), pp. 458-465
[53.]
J.B. Gordon, P. Ganz, E.G. Nabel, R.D. Fish, J. Zebede, G.H. Mudge, et al.
Atherosclerosis and endothelial function influence the coronary vasomotor response to exercise.
J Clin Invest, 83 (1989), pp. 1946-1952
[54.]
D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan, et al.
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.
Lancet, 340 (1992), pp. 1111-1115
[55.]
T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, et al.
Close relationship of endothelial function in the human coronary and peripheral circulations.
J Am Coll Cardiol, 26 (1995), pp. 1235-1241
[56.]
J.A. Panza, A.A. Quyyumi, J.E. Brush Jr., S.E. Epstein.
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.
N Engl J Med, 323 (1990), pp. 22-27
[57.]
H.O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, A.D. Baron.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
J Clin Invest, 97 (1996), pp. 2601-2610
[58.]
M. Hashimoto, M. Akishita, M. Eto, K. Kozaki, J. Ako, N. Sugimoto, et al.
The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation.
Int J Obesity, 22 (1998), pp. 477-484
[59.]
E. Ros, C. Rodríguez-Villar, I. Núñez, R. Gilabert, I. Conget.
Endothelial dysfunction in healthy subjects without cardiovascular risk factors but with variable adiposity is related to visceral fat accumulation [abstract].
Eur J Clin Invest, 31 (2001), pp. 26
[60.]
A.A. Brown, F. Hu.
Dietary modulation of endothelial function: implications for cardiovascular disease.
Am J Clin Nutr, 73 (2001), pp. 673-686
[61.]
F. Fuentes, F. López-Miranda, E. Sánchez, F. Sánchez, J. Paez, E. Paz-Rojas, et al.
Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.
Ann Intern Med, 134 (2001), pp. 1115-1119
[62.]
R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, et al.
Effect of exercise on coronary endothelial function in patients with coronary artery disease.
N Engl J Med, 342 (2000), pp. 454-460
[63.]
J.A. Suwaida, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes, A. Lerman.
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.
Circulation, 101 (2000), pp. 948-954
[64.]
V. Schachinger, M.B. Britten, A.M. Zeiher.
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
Circulation, 101 (2000), pp. 1899-1906
[65.]
F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, et al.
Prognostic significance of endothelial dysfunction in hypertensive patients.
Circulation, 104 (2001), pp. 191-196
[66.]
M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager, et al.
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force.
J Am Coll Cardiol, 39 (2002), pp. 257-265
[67.]
H. Etsuda, B. Takase, A. Uehata, H. Kusano, A. Hamabe, R. Kuhara, et al.
Morning attenuation of endothelium-dependent, flow-mediated dilation in healthy young men: possible connection to morning peak of cardiac events.
Clin Cardiol, 22 (1999), pp. 417-421
[68.]
K.J. Harjai.
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
Ann Intern Med, 131 (1999), pp. 376-386
[69.]
P.M. Ridker.
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Circulation, 103 (2001), pp. 1813-1818
[70.]
X. Garcia-Moll, J.C. Kaski.
Proteína C reactiva como factor de riesgo coronario.
Med Clin (Barc), 117 (2001), pp. 303-308
[71.]
R. Ross.
Atherosclerosis: an inflammatory disease.
N Engl J Med, 340 (1999), pp. 115-126
[72.]
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, et al.
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.
BMJ, 321 (2000), pp. 199-204
[73.]
L.H. Kuller, L. Shemanski, B.M. Psaty, N.O. Borhani, J. Gardin, M.N. Haan, et al.
Subclinical disease as an independent risk factor for cardiovascular disease.
Circulation, 92 (1995), pp. 720-726
[74.]
I. Kronzon, P.A. Tunick.
Atheromatous disease of the thoracic aorta: pathologic and clinical implications.
Ann Intern Med, 126 (1997), pp. 629-637
[75.]
A.B. Newman, A.M. Arnold, G.L. Burke, D.H. O’Leary, T.A. Manolio.
Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: the Cardiovascular Health Study.
Ann Intern Med, 134 (2001), pp. 182-190
[76.]
L.A. Prosser, A.A. Stinnett, P.A. Goldman, L.W. Williams, M.G. Hunink, L. Goldman, M.C. Weinstein.
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.
Ann Intern Med, 132 (2000), pp. 769-779
[77.]
J. Gómez-Gerique.
Evaluación farmacoeconómica de la reducción del colesterol con inhibidores de la HMG-CoA reductasa (estatinas) en la hipercolesterolemia.
Clin Invest Arterioscler, 134 (2001), pp. 241-253
Trabajo realizado en parte gracias a becas FIS 93/0596, FIS 00/0992 y Telemaratón TV3 Diabetes 1999.
Copyright © 2002. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.